Joint pain continues to emerge as one of the most debilitating conditions among Australia’s aging population but that can now be addressed with superfoods company LiveVerdure’s (ASX: LV1) latest product TheraJoint+, turmeric capsules that have been approved by Australia’s Therapeutic Goods Association (TGA). TheraJoint+ is part of LiveVerdure’s 13 Seeds brand and is the brand’s
Read More
New Zealand’s leading BNPL provider, Laybuy (ASX: LBY) has reported an impressive year across the board, proving that there is space yet to grow in the seemingly saturated sector. Since its inception in 2017, Laybuy has gone from strength to strength with a seemingly well timed entry into the BNPL market. Laybuy is now recognised
Read More
Adelaide-based medtech company LBT Innovations (ASX: LBT) is moving nicely along the path to commercialise their flagship product, presenting clinical data at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which will be held online over the weekend. The ECCMID represents the largest global conference for clinical microbiology and is a unique opportunity
Read More
Pain management is one of the most fascinating arms of medicine. Post-operative pain management, even more so. Practitioners must strike a balance to ensure that acute pain doesn’t turn into chronic pain, and that a patient’s dependence on analgesia is temporary. The many issues with opioid based pain medications are well documented and, with a
Read More
Just hanging up the cleats a few months ago, future NFL Hall-of-Fame quarterback Drew Brees will not be lost to sporting fans around the world having quickly been snapped up by sportsbetting company PointsBet (ASX: PBH) as their newest brand ambassador. Brees, who was loved by all NFL fans as one of the greatest quarterbacks
Read More
In the wake of a pandemic which has led to much more time spent at home, Australians have been a productive bunch, spending big on technology products. That spending has shown no signs of slowing down either, with eCommerce company Harris Technology (ASX: HT8) reporting a 209% increase in revenue to $42 million. Interestingly, the
Read More
Touted as a miracle cure for just about any ailment, medicinal cannabis has been an interesting point of contention in healthcare for years now. The media hype around the stuff has increased, patient demand has increased, and global production is booming (legally). Canadian based Wolf Island Cannabis is currently constructing a cannabis cultivation facility in
Read More
Investors who participated in the IPO of respiratory equipment manufacturer CleanSpace (ASX: CSX) will be concerned as to how the company can turn their fortunes around, following a massive decline in sales which keen pundits had expected in the wake of a recovering pandemic. For the Half-Year ended 30 June 2021, CleanSpace generated $10.2m from
Read More
Once upon a time, stress ensured our survival. When faced with a dangerous situation our body responds instantly- heart rate increases, blood pressure climbs and muscles tighten as the body prepares to deal with the bear/ exam you’ve been presented with. In the modern world we are faced with a disproportionately higher amount of exams
Read More
Fresh off their declaration to be a net-zero carbon emissions business before 2050, oil and gas company Carnarvon Petroleum (ASX: CVN) has committed $2.6 million into a joint venture project aiming to produce renewable diesel and other sustainable products, including graphene. The fund will secure a 50% equity stake in the venue in partnership with
Read More
